Asst Prof Ashish Khanna (Cleveland, USA) discusses the ATHOS-3 trial, investigating angiotensin II in vasodilatory shock at the Critical Care Reviews Meeting 2018 in Belfast. Prof Anthony Gordon (London, England) provides a brief editorial afterwards.
